OrganizationsOrganization

Hypera

HYPE3

Brazil's largest domestically owned pharmaceutical company, owner of brands such as Neosaldina, Buscopan and Benegrip plus generics and branded generics, listed on B3 as HYPE3.

1articles

2material mentions

0connections

Last 90 days

What sources are saying

Hypera began selling its Semavy semaglutide pen on September 4 at R$ 333, with a pledge to freeze the price, per Exame, g1 and CNN Brasil.

Updated September 05, 2026 · 1 verified article

Market transmission

Why it matters

The stock tracks product launches and patent expiries, the annual CMED-regulated price adjustment, retail pharmacy inventories and leverage after acquisitions.

Explanatory mechanism, not a forecast or recommendation.

Articles in chronological order

EMPRESASBrazil

Hypera starts selling its Semavy semaglutide pen at R$ 333 per unit in a three-pen kit

Hypera began selling on September 4 its Semavy semaglutide pen at R$ 333 per pen in a three-unit kit, R$ 999 in total, per Exame, g1 and CNN Brasil. Per Exame, the company's chief executive said the price will stay frozen to retain customers; per CNN Brasil, a single pen costs R$ 464.80.

3 sourcesSep 04, 2026